Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Silke Raats"'
Autor:
Angelina Konnova, Fien H. R. De Winter, Akshita Gupta, Lise Verbruggen, An Hotterbeekx, Matilda Berkell, Laure-Anne Teuwen, Greetje Vanhoutte, Bart Peeters, Silke Raats, Isolde Van der Massen, Sven De Keersmaecker, Yana Debie, Manon Huizing, Pieter Pannus, Kristof Y. Neven, Kevin K. Ariën, Geert A. Martens, Marc Van Den Bulcke, Ella Roelant, Isabelle Desombere, Sébastien Anguille, Zwi Berneman, Maria E. Goossens, Herman Goossens, Surbhi Malhotra-Kumar, Evelina Tacconelli, Timon Vandamme, Marc Peeters, Peter van Dam, Samir Kumar-Singh
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
BackgroundPatients with cancer, especially hematological cancer, are at increased risk for breakthrough COVID-19 infection. So far, a predictive biomarker that can assess compromised vaccine-induced anti-SARS-CoV-2 immunity in cancer patients has not
Externí odkaz:
https://doaj.org/article/ad857598e2b741baaf1d0d02701cbefe
Autor:
Angelina Konnova, Fien HR De Winter, Akshita Gupta, Lise Verbruggen, An Hotterbeekx, Matilda Berkell, Laure-Anne Teuwen, Greetje Vanhoutte, Bart Peeters, Silke Raats, Isolde Van der Massen, Sven De Keersmaecker, Yana Debie, Manon Huizing, Pieter Pannus, Kristof Y Neven, Kevin K Ariën, Geert A. Martens, Marc Van Den Bulcke, Ella Roelant, Isabelle Desombere, Sébastien Anguille, Zwi Berneman, Maria E Goossens, Herman Goossens, Surbhi Malhotra-Kumar, Evelina Taconelli, Timon Vandamme, Marc Peeters, Peter van Dam, Samir Kumar-Singh
BackgroundPatients with cancer, especially haematological cancer, are at increased risk for breakthrough COVID-19 infection. However, so far, a predictive biomarker that can assess compromised vaccine-induced anti-SARS-CoV-2 immunity in cancer patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::73724b23ab84d307f26b1c7e555afd15
https://doi.org/10.1101/2022.09.25.22280267
https://doi.org/10.1101/2022.09.25.22280267
Autor:
Pieter Pannus, Kevin K. Ariën, Sébastien Anguille, Marc Peeters, Kristof Y. Neven, Peter van Dam, Manon T. Huizing, Isabelle Desombere, Ella Roelant, Laure-Anne Teuwen, Marc Van Den Bulcke, Isolde Van der Massen, Sara Vande Kerckhove, Geert A. Martens, Sven De Keersmaecker, Timon Vandamme, Silke Raats, Greetje Vanhoutte, Lise Verbruggen, Bart Peeters, Maria E Goossens
Publikováno v:
SSRN Electronic Journal.
Background: Cancer patients are at higher risk of developing severe COVID-19. However, safety and efficacy of COVID-19 vaccination in cancer patients undergoing treatment is unclear. Methods: In this interventional prospective multi-cohort study, pri